Patents by Inventor Pura J. Requintina

Pura J. Requintina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Inhibiting Lipid Peroxidation
    Publication number: 20080200557
    Abstract: The invention relates generally to the use of N-substituted dopamine derivatives for the treatment of diseases and disorders that involve abnormal lipid peroxidation. This method comprises the administration of a pharmaceutically effective amount of N-acetyldopamine derivatives or N-alkyldopamine derivatives and a pharmaceutically acceptable carrier for treating an animal or human suffering abnormal lipid peroxidation. The N-acetyldopamine derivative or N-alkyldopamine derivatives may be administered alone or in combination with N-acetylserotonin (NAS) to inhibit lipid peroxidation.
    Type: Application
    Filed: July 7, 2005
    Publication date: August 21, 2008
    Applicant: CARITAS ST. ELIZABETH HOSPITAL OF BOSTON, INC.
    Inventors: Gregory Okenkrug, Pura J. Requintina
  • Method of treating neurodegenerative disorders
    Patent number: 6353015
    Abstract: This invention relates to the use of N-acetyl-serotonin (NAS) derivatives for the treatment and prophylaxis of neurological injury and neurodegenerative disorders in a mammal.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: March 5, 2002
    Assignee: St. Elizabeth's Medical Center
    Inventors: Gregory F. Oxenkrug, Sergei O. Bachurin, Andrey Zakharovic Afanasiev, Pura J. Requintina
  • Method for treating hypertension
    Patent number: 6063805
    Abstract: The present invention relates to a method of treatment of hypertension in a mammal, particularly a human being. This method comprises the administration of a therapeutically effective hypertension treatment amount of N-acetylserotonin (NAS) to the mammal.
    Type: Grant
    Filed: November 4, 1998
    Date of Patent: May 16, 2000
    Assignee: St. Elizabeth's Medical Center of Boston
    Inventors: Gregory F. Oxenkrug, Pura J. Requintina
  • Method for treating depression, obsessive compulsive disorder, and anxiety with N--acetyl serotonin
    Patent number: 6011054
    Abstract: The present invention relates to a method of treatment of depression in a human being identified as having depression. This method comprises the administration of a therapeutically effective depression treatment amount of N-acetyl-serotonin (NAS), also referred to as N-acetyl-5-hydroxytryptamine, to a human being identified as having depression. The NAS may be administered alone or in combination with other agents, e.g., Ca.sup.++ antagonists.
    Type: Grant
    Filed: November 4, 1998
    Date of Patent: January 4, 2000
    Assignee: St. Elizabeth's Medical Center of Boston
    Inventors: Gregory F. Oxenkrug, Pura J. Requintina